Insulet
PODD
$166.19
Share price
1.23%
Change (1 day)
-47.75%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Cash on Hand
Cash on Hand as of December 2023 : $0.70 B
According to Insulet's latest financial reports the company has $0.70 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Insulet - Cash on Hand chart (from 2005 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.70 B | 4.45% |
| 2022-12-31 | $0.67 B | -14.66% |
| 2021-12-31 | $0.79 B | -16.63% |
| 2020-12-31 | $0.94 B | 151.95% |
| 2019-12-31 | $0.37 B | 30.18% |
| 2018-12-31 | $0.28 B | -34.35% |
| 2017-12-31 | $0.44 B | 47.39% |
| 2016-12-31 | $0.29 B | 143.39% |
| 2015-12-31 | $0.12 B | -18.86% |
| 2014-12-31 | $0.15 B | 0.98% |
| 2013-12-31 | $0.14 B | 161.34% |
| 2012-12-31 | $57.29 M | -39.02% |
| 2011-12-31 | $93.95 M | -17.06% |
| 2010-12-31 | $0.11 B | -11.5% |
| 2009-12-31 | $0.12 B | 125.89% |
| 2008-12-31 | $56.66 M | -40.09% |
| 2007-12-31 | $94.58 M | 184.64% |
| 2006-12-31 | $33.23 M | 333.83% |
| 2005-12-31 | $7.66 M | -68.08% |
| 2004-12-31 | $23.99 M | 454.51% |
| 2003-12-31 | $4.32 M | -74.49% |
| 2002-12-31 | $16.96 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 3,155.75% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 933.66% | 🇺🇸 USA |
 Medtronic MDT | $8.32 B | 1,081.62% | 🇮🇪 Ireland |
 Eli Lilly LLY | $2.92 B | 315.75% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.46 B | -33.55% | 🇺🇸 USA |
 ICU Medical
ICUI | $0.25 B | -63.83% | 🇺🇸 USA |
 DexCom DXCM | $2.89 B | 311.39% | 🇺🇸 USA |